ASTRAZENECA DL-,25 SP.ADR
ASTRAZENECA DL-,25 SP.ADR/ US0463531089 /
ZEGA
|
23/01/2025 15:39:52
|
Var.
+0.50
|
Volume |
Denaro18:23:42 |
Lettera18:23:42 |
Capitalizzazione di mercato |
Dividend Y. |
Rapporto P/E |
|
66.00EUR
|
+0.76%
|
5
Fatturato: 330 |
65.50Quantità in denaro: 380 |
66.00Quantità in lettera: 380 |
204.16 bill.EUR |
- |
- |
Descrizione business
AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.
Consiglio di amministrazione & Consiglio di sorveglianza
| CEO |
| Pascal Soriot |
| Consiglio di amministrazione |
| Aradhana Sarin, Pam Cheng, Ruud Dobber, Marc Dunoyer, David Fredrickson, Susan Galbraith, Jeff Pott, Iskra Reic, Sharon Barr |
| Consiglio di sorveglianza |
| Michel Demaré, Pascal Soriot, Aradhana Sarin, Philip Broadley, Euan Ashley, Deborah DiSanzo, Diana Layfield, Sheri McCoy, Tony Mok, Nazneen Rahman, Andreas Rummelt, Marcus Wallenberg, Anna Manz, Rene Haas |
Dati aziendali
| Name: |
AstraZeneca plc |
| Indirizzo: |
1 Francis Crick Avenue Cambridge Biomedical Campus,Cambridge, CB2 0AA United Kingdom |
| Telefono: |
0800 783 0033 |
| Fax: |
+44-20-7604-8151 |
| E-mail: |
Medical.InformationU...eca.com
Medical.InformationUK@astrazeneca.com
|
| Internet: |
www.astrazeneca.com |
| Industria: |
Healthcare |
| Settore: |
Pharmaceutical Industry |
| Sub settore: |
Pharmaceuticals |
| Fine dell'anno finanziario: |
31/12 |
| Flottante libero: |
- |
| Data dell'IPO: |
06/04/1999 |